SOCRA Practice Test

Sample Questions and Answers

Question 1. During a clinical trial, a participant asks additional questions after signing the informed consent form and before receiving the investigational treatment. What is the most appropriate response from the clinical research professional?

A. Explain that no additional questions can be answered after the consent form has been signed.

B. Answer the participant’s questions, confirm continued willingness to participate, and ensure informed consent remains an ongoing process.

C. Tell the participant to wait until the study has been completed.

D. Refer every question to another participant enrolled in the study.

Correct Answer: B. Answer the participant’s questions, confirm continued willingness to participate, and ensure informed consent remains an ongoing process.

Explanation:
Informed consent is not a single event that ends when the consent form is signed. It is an ongoing communication process throughout a participant’s involvement in a clinical study. Research professionals should provide accurate information, answer questions honestly, verify that participants continue to understand the study, and confirm their voluntary willingness to participate. Maintaining open communication supports participant autonomy, ethical research conduct, and regulatory compliance. Protecting participants’ rights and ensuring informed decision-making are fundamental responsibilities under Good Clinical Practice (GCP) guidelines and are frequently assessed on the SOCRA CCRP certification exam.

Question 2. During routine source document review, a clinical research coordinator discovers that one laboratory result recorded in the case report form does not match the original medical record. What should be the coordinator’s first action?

A. Ignore the discrepancy because it is only a single data value.

B. Review the source documentation, verify the correct information, and resolve the discrepancy according to study procedures.

C. Delete the laboratory result from every study record.

D. Estimate the correct value based on previous laboratory results.

Correct Answer: B. Review the source documentation, verify the correct information, and resolve the discrepancy according to study procedures.

Explanation:
Accurate data collection is essential for maintaining the integrity of clinical research. When discrepancies are identified between source documents and case report forms, research personnel should verify the original information, determine the correct value, document the resolution appropriately, and follow study-specific procedures for correcting the record. Data should never be estimated or altered without proper documentation. Maintaining complete, accurate, and verifiable study records supports participant safety, regulatory compliance, and the scientific reliability of clinical trial results. Data integrity is a core competency evaluated on the SOCRA certification examination.

Question 3. During an investigational drug study, a participant experiences a serious medical event that may be related to the study treatment. What should the research team prioritize first?

A. Delay reporting until the participant completes the study.

B. Ensure participant safety, document the event accurately, and follow protocol and regulatory reporting requirements.

C. Remove all references to the event from the study records.

D. Wait until the sponsor requests additional information before taking action.

Correct Answer: B. Ensure participant safety, document the event accurately, and follow protocol and regulatory reporting requirements.

Explanation:
Participant safety is the highest priority in every clinical research study. When a serious adverse event occurs, research personnel should provide or arrange appropriate medical care, document the event completely, assess the relationship to the investigational product as required, and report the event according to the study protocol, institutional policies, and regulatory requirements. Timely reporting supports ongoing safety monitoring and helps protect current and future study participants. Proper adverse event management is an essential component of Good Clinical Practice and represents an important area of knowledge tested on the SOCRA CCRP exam.

Question 4. During a monitoring visit, the clinical research monitor requests access to study records to verify protocol compliance and data accuracy. Why is maintaining complete and organized study documentation important?

A. It only improves the appearance of the research files.

B. It supports data integrity, regulatory compliance, participant protection, and accurate verification of study activities.

C. Documentation is only necessary after the study has ended.

D. Source documents may be discarded once data are entered into the database.

Correct Answer: B. It supports data integrity, regulatory compliance, participant protection, and accurate verification of study activities.

Explanation:
Clinical research documentation serves as the official record of study conduct and participant care. Accurate, complete, and organized records allow monitors, auditors, sponsors, and regulatory authorities to verify that the study was conducted according to the approved protocol and applicable regulations. Proper documentation also protects participant safety, supports reliable data analysis, and demonstrates compliance with Good Clinical Practice standards. Maintaining high-quality documentation throughout every stage of a clinical trial is a fundamental responsibility of clinical research professionals and is commonly evaluated on certification examinations.

Question 5. Before enrolling a participant in a clinical study, a research coordinator reviews the study’s inclusion and exclusion criteria. What is the primary purpose of this eligibility review?

A. To increase enrollment regardless of participant suitability.

B. To ensure that only individuals who meet the protocol requirements are enrolled, protecting participant safety and study validity.

C. To shorten the informed consent process.

D. To reduce the amount of study documentation required.

Correct Answer: B. To ensure that only individuals who meet the protocol requirements are enrolled, protecting participant safety and study validity.

Explanation:
Eligibility criteria are established to enroll participants who are appropriate for the research objectives while minimizing unnecessary risks. Reviewing inclusion and exclusion criteria before enrollment helps ensure participant safety, improves study consistency, and supports the scientific validity of trial results. Enrolling ineligible participants may compromise data quality, increase safety concerns, and create regulatory compliance issues. Research coordinators must carefully verify eligibility using protocol requirements and source documentation before enrollment. Proper participant selection is a fundamental aspect of ethical clinical research and is frequently tested on the SOCRA Certified Clinical Research Professional (CCRP) examination.